This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2i66

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2i66.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2i66.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2i66| PDB=2i66 | SCENE= }}
{{STRUCTURE_2i66| PDB=2i66 | SCENE= }}
-
'''Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis'''
+
===Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis===
-
==Overview==
+
<!--
-
The enzymatic cleavage of the nicotinamide-glycosidic bond on nicotinamide adenine dinucleotide (NAD(+)) has been proposed to go through an oxocarbenium ion-like transition state. Because of the instability of the ionic intermediate, there has been no structural report on such a transient reactive species. Human CD38 is an ectoenzyme that can use NAD(+) to synthesize two calcium-mobilizing molecules. By using NAD(+) and a surrogate substrate, NGD(+), we captured and determined crystal structures of the enzyme complexed with an intermediate, a substrate, and a product along the reaction pathway. Our results showed that the intermediate is stabilized by polar interactions with the catalytic residue Glu(226) rather than by a covalent linkage. The polar interactions between Glu(226) and the substrate 2',3'-OH groups are essential for initiating catalysis. Ser(193) was demonstrated to have a regulative role during catalysis and is likely to be involved in intermediate stabilization. In addition, a product inhibition effect by ADP-ribose (through the reorientation of the product) or GDP-ribose (through the formation of a covalently linked GDP-ribose dimer) was observed. These structural data provide insights into the understanding of multiple catalysis and clues for drug design.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16951430}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16951430 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16951430}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Reaction product]]
[[Category: Reaction product]]
[[Category: The catalytic pocket]]
[[Category: The catalytic pocket]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:07:22 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 05:20:57 2008''

Revision as of 02:20, 28 July 2008

Image:2i66.png

Template:STRUCTURE 2i66

Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysis

Template:ABSTRACT PUBMED 16951430

About this Structure

2I66 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis., Liu Q, Kriksunov IA, Graeff R, Munshi C, Lee HC, Hao Q, J Biol Chem. 2006 Oct 27;281(43):32861-9. Epub 2006 Sep 2. PMID:16951430

Page seeded by OCA on Mon Jul 28 05:20:57 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2i66"
Personal tools